Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Debt / NOTE 0.599% 8/0
-
Number of holders
-
55
-
Total 13F principal, excl. options
-
454,044,750
-
Principal change
-
+13,368,000
-
Total reported value, excl. options
-
$446,464,227
-
Value change
-
+$12,893,132
-
Number of buys
-
23
-
Number of sells
-
27
-
Price
-
$0.9838
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 as of Q1 2024
As of 31 Mar 2024 BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 had 71 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $454,044,750 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included LORD, ABBETT & CO. LLC, Voya Investment Management LLC, LAZARD ASSET MANAGEMENT LLC, BANK OF AMERICA CORP /DE/, MILLENNIUM MANAGEMENT LLC, CITIGROUP INC, AVIVA PLC, SONA ASSET MANAGEMENT (US) LLC, TENOR CAPITAL MANAGEMENT Co., L.P., and Shaolin Capital Management LLC.
This table shows 71 bond principal holders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.